New Cancer Drugs Are Revolutionary. Why Don’t More Patients Get Them?
Image: The New York Times
ad slot · in-content video 16:9
Coverage
Wires & papers of record
- Targeted gene therapies are highly effective at stopping cancers, but the very abundance of the treatments, plus cost and sluggish change, are hindering access.